Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;26(5):e14298.
doi: 10.1111/petr.14298. Epub 2022 Apr 22.

Predictors of portal vein complications after pediatric liver transplantation: A German center experience

Amr Badawy  1   2 , Stefan M Brunner  1 , Birgit Knoppke  3 , Melanie Völkl  3 , Henrik Junger  1 , Martin Loss  1 , Barbara Sinner  4 , Veronika Huf  4   5 , Dirk Grothues  3 , Michael Melter  3 , Hans J Schlitt  1
Affiliations

Predictors of portal vein complications after pediatric liver transplantation: A German center experience

Amr Badawy et al. Pediatr Transplant. 2022 Aug.

Abstract

Background: Portal vein complications (PVCs) after pediatric liver transplantation (LT) are sometimes asymptomatic, especially in the early phase, and can threaten both the graft and patient's survival. Therefore, the purpose of this study is to analyze the risk factors for portal vein thrombosis (PVT) and portal vein stenosis (PVS) after pediatric LT.

Methods: All pediatric patients (n = 115) who underwent primary LT at Regensburg University Hospital between January 2010 and April 2017 were included in this study. The pre-, intra-, and postoperative parameters of all patients were retrospectively reviewed and risk factors for both PVT and PVS were analyzed.

Results: Of the 115 patients, living donor LT was performed on 57 (49.5%) patients, and biliary atresia was the primary diagnosis in 65 patients (56%). After pediatric LT, 9% of patients developed PVT, and 16.5% developed PVS. Patient weight ≤7 kg [odds ratio (OR) 9.35, 95% confidence interval (CI) 1.03-84.9, p = .04] and GRWR >3% (OR 15.4, 95% CI 1.98-129.5, p = .01) were the independent risk factors for the development of PVT and PVS, respectively upon multivariate analysis. The overall patient survival rates at 1, 3, and 5 years were 91%, 90%, and 89%, respectively, and there was no difference in patient survival among those with and without PVCs.

Conclusions: Pediatric patients with body weight <7 kg and/or receiving a graft with GRWR >3% may develop PVCs and so require certain surgical modifications, close follow-up, and prophylactic anticoagulant therapy following transplant.

Keywords: liver transplant; pediatric; portal vein stenosis; portal vein thrombosis; risk factors.

PubMed Disclaimer

References

REFERENCES

    1. Alfares BA, Bokkers RPH, Verkade HJ, et al. Portal vein obstruction after pediatric liver transplantation: a systematic review of current treatment strategies. Transplant Rev. 2021;35(4):100630. 10.1016/j.trre.2021.100630
    1. Patel R, Mahaveer J, Tahir N, et al. Outcomes of percutaneous portal vein intervention in a single UK paediatric liver transplantation programme. Cardiovasc Intervent Radiol. 2018;41(1):96-103. 10.1007/s00270-017-1792-0
    1. Shibasaki S, Taniguchi M, Shimamura T, et al. Risk factors for portal vein complications in pediatric living donor liver transplantation. Clin Transplant. 2010;24(4):550-556.
    1. Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM. Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl. 2013;19(3):315-321.
    1. Orlandini M, Feier FH, Jaeger B, Kieling C, Vieira SG, Zanotelli ML. Frequency of and factors associated with vascular complications after pediatric liver transplantation. J Pediatr (Rio J). 2014;90(2):169-175.